ClinicalTrials.Veeva

Menu

Impact of Long Term of Benzodiazepine Use on Psychiatric Manifestation

A

Assiut University

Status

Unknown

Conditions

Psychiatric Disorder
Benzodiazepine-Related Disorders

Treatments

Behavioral: The Minnesota Multiphasic Personality Inventory-2 (MMPI-2)
Behavioral: the Hamilton Depression Rating Scale
Behavioral: Intelligence assessment using the Arabic version of the Wechsler Adult Intelligence Scale (WAIS)
Behavioral: Detailed interview with personal demographic data
Behavioral: The Hamilton Anxiety Rating Scale
Behavioral: The Arabic version of the Structured Interview for the Five-Factor Personality Model (SIFFM)

Study type

Observational

Funder types

Other

Identifiers

NCT04792658
long term of benzodiazepine

Details and patient eligibility

About

Benzodiazepines are usually a secondary drug of abuse-used mainly to augment the high received from another drug or to offset the adverse effects of other drugs. Few cases of addiction arise from legitimate use of benzodiazepines. Pharmacologic dependence, a predictable and natural adaptation of a body system long accustomed to the presence of a drug, may occur in patients taking therapeutic doses of benzodiazepines. However, this dependence, which generally manifests itself in withdrawal symptoms upon the abrupt discontinuation of the medication, may be controlled and ended through dose tapering, medication switching, and/or medication augmentation. Due to the chronic nature of anxiety, long-term low-dose benzodiazepine treatment may be necessary for some patients; this continuation of treatment should not be considered abuse or addiction.

previous study reported that The results of the study are important in that they corroborate the mounting evidence that a range of neuropsychological functions are impaired as a result of long-term benzodiazepine use, and that these are likely to persist even following withdrawal. The findings highlight the residual neurocognitive compromise associated with long-term benzodiazepine therapy as well as the important clinical implications of these results.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age from 18 years to 50 years
  • No history of neurological or medical illness

Exclusion criteria

  • intelligence score more than 80

Trial contacts and locations

0

Loading...

Central trial contact

gellan Ahmed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems